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Background: Substance abuse continues to exact a significant toll, despite promising advancements in treatment,
and American Indian and Alaska Native (AI/AN) communities remain disproportionately impacted. Understanding
the challenges to providing quality substance abuse treatment to AI/AN communities could ultimately result in
more effective treatment interventions, but no multi-site studies have examined this important issue.
Methods: This qualitative study examined the challenges of providing substance abuse treatment services for
American Indian and Alaska Native (AI/AN) communities. We conducted key informant interviews and focus groups at
18 substance abuse treatment programs serving AI/AN communities. Seventy-six service participants (21 individuals in
clinical administrative positions and 55 front-line clinicians) participated in the project. Interview transcripts were coded
to identify key themes.
Results: We found that the challenges of bringing effective substance abuse treatment to AI/AN communities fell into
three broad categories: challenges associated with providing clinical services, those associated with the infrastructure of
treatment settings, and those associated with the greater service/treatment system. These sets of challenges interact to
form a highly complex set of conditions for the delivery of these services.
Conclusions: Our findings suggest that substance abuse treatment services for AI/AN communities require more
integrated, individualized, comprehensive, and longer-term approaches to care. Our three categories of challenges
provide a useful framework for eliciting challenges to providing quality substance abuse treatment in other substance
abuse treatment settings.
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studiesBackground
Despite promising advances in biopsychosocial treatments,
substance use disorders continue to significantly impact the
health of people worldwide, due in part to the treatment gap
between optimal care and currently available services [1].
For example, in the United States, the Institute of Medicine’s
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ination of and critical gaps in the existing evidence base
result in ineffective treatment practices [2]. Other issues
reducing the quality of substance abuse treatment include
discrimination and stigma, poor coordination of substance
abuse services with mental health and medical care, incon-
sistent licensing requirements, and an inadequately trained
workforce [2-4]. Unlike the majority of medical care in the
United States, substance abuse treatment relies primarily on
public rather than private sources, resulting in chronic
underfunding. The substance abuse treatment infrastructure
is further undermined by high rates of staff turnover andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Legha et al. BMC Psychiatry 2014, 14:181 Page 2 of 10
http://www.biomedcentral.com/1471-244X/14/181treatment center closures and by overwhelming data collec-
tion requirements for accreditation and reimbursement
[3,5,6]. Additionally, unlike other developed countries such
as the United Kingdom, in the United States no centralized
authority mandates the implementation of uniform stan-
dards or evidence-based practices [7]. Though substance
abuse disorders are chronic conditions often associated with
complex medical and psychiatric comorbidities as well as
severe impairment in multiple areas of functioning [8,9], the
current service model provides inadequate, short-term
services that fail to address patients’ long-term addiction
treatment and social support needs [10-12]. Further-
more, there are too few programs available to those
who need treatment [13].
American Indian and Alaska Native (AI/AN) communi-
ties face additional challenges in pursuing quality substance
abuse treatment, including high levels of need. AI/ANs
suffer disproportionately from substance use disorders
and their physical and emotional health consequences
[14-16]. Only 1 in 8 AI/AN adults needing treatment
receives it at a specialized facility [17], a rate comparable
to the national average. However, AI/AN communities’
health services receive significantly lower per capita
spending than health services in the rest of the United
States, meaning their substantial needs are not matched
by a comparable commitment of resources [18,19].
Treatment barriers further interfering with meeting
these needs include geographical remoteness, poverty,
poor transportation infrastructures, and a shortage of
qualified providers. Due to their history of oppression
and mistreatment, AI/AN communities also harbor
mistrust towards institutional sources of care [20,21].
Many AI/AN people may question the utility of western
approaches to healing and instead rely on traditional,
indigenous approaches exclusively [20]. Evidence-based
practices could potentially improve services, but AI/AN
treatment programs and academics have raised concerns
regarding their cultural appropriateness, inadequate gui-
dance to adapt them for use with AI/AN patients, and
even their applicability to AI/AN populations, which are
rarely included in research efforts [22,23].
Understanding the challenges service providers face in their
efforts to provide quality substance abuse treatment services
to AI/AN communities could ultimately result in the design
of more effective care. In a previous analysis of data from this
same study, we identified specific challenges to addressing
cultural issues in treatment in these communities. These
included the within-community diversity of AI/ANs, lack of
available resources to provide culturally-based services (e.g.,
access to traditional healers), and pressure from funders to
focus on evidence-based practices [24]. To our knowledge,
no multi-site studies have addressed this important issue of
challenges to providing quality substance abuse services for
AI/AN communities more broadly. This study's purposeis to use qualitative data analyses of 21 interviews and
10 focus groups at 18 treatment centers nationwide to
identify the challenges alcohol and substance abuse
treatment centers for AI/AN communities face in pro-
viding meaninful and effective treatment.
Methods
Data for these analyses come from the second phase of
the Centers for American Indian and Alaska Native
Health’s Evidence-Based Practices and Substance Abuse
Treatment for Native Americans project. This study’s
primary aims are to: a) describe the use of specific
evidence-based treatments (EBTs) in substance abuse
treatment programs serving American Indian and Alaska
Native communities; b) describe the factors associated
with the implementation of evidence-based treatments
in these programs; and c) identify methods for more
effective dissemination of evidence-based treatments to
substance abuse treatment programs serving American
Indian and Alaska Native communities. This project
also examines how treatment programs design, implement,
and assess their services and incorporate evidence-based
concepts and traditional healing techniques into these
services [24].
An Advisory Board supports this project. Members
include administrators, providers, evaluators from the
AI/AN substance abuse treatment community, and
researchers with expertise in AI/AN substance abuse
treatment and dissemination research. Phase 1 consisted
of extensive Advisory Board discussions of the issues
related to delivering quality substance abuse treatment
services in AI/AN communities and the place of EBTs
in these services [22]. Phase 2 consisted of “program
case studies” involving visits to treatment programs and
qualitative data collection about the communities served,
services offered, challenges to delivering these services,
and EBT use [24]. In the third and final stage of the
project, clinical directors of 445 behavioral health pro-
grams nationwide were asked to complete a 45-minute
survey about their program and experience with EBTs
[25]. Data for these analyses are drawn from the Phase
2 program case studies.
Settings and participants
For Phase 2, the Advisory Board identified programs
based on their reputations for innovative clinical services
and to assure adequate representation of the geographic,
cultural, and reservation/rural/urban diversity of AI/AN
communities. The criteria for innovative clinical services
included a) combining cultural and biomedical treatment
approaches, b) incorporating evidence-based practices
into treatment, and c) receiving competitive federal
funding for service implementation and expansion. Our
initial letters of inquiry, which were directed to program
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explained the study’s purpose, invited programs to par-
ticipate, and explicitly reassured programs, their host
tribes/organizations, and individual participants of their
confidentiality [26,27]. All eighteen substance abuse treat-
ment programs invited to participate in the program case
study component of this study agreed to participate. We
deliberately emphasized confidentiality throughout this
study in order to maximize participation and minimize
organizational and participant discomfort. Such discom-
fort is not uncommon in AI/AN communities due to prior
research abuses and the stigma of mental illness [21,22].
Accordingly, for the focus group and key informant
interviews, we did not collect individual participants’
demographic information, and instead focused on the key
topics of interest for this study. Focus groups included
program staff in front-line clinical positions. Because of
the small size of many programs, we purposely included
representatives from multiple treatment programs within
the same tribe, tribal consortium, or urban organization in
a single focus group. Though this approach required more
effort from the interviewer to collect specific information
about each program, we prioritized having a larger
group to facilitate richer conversation over much smaller
program-specific focus groups. At each of the eighteen
participating programs, we also conducted one or more
key informant interviews with program staff in clinical
administrative positions. We chose to focus on inter-
views of staff members and did not interview patients
receiving services because of this study’s primary aim of
describing the use of specific evidence-based treatments
in these substance abuse treatment programs. Furthermore,
evaluating staff perspectives represents a practical starting
point for understanding the challenges of providing quality
substance abuse treatment. Data collection took place from
August 2009 through July 2010.
As indicated in Table 1, these eighteen programs
reside within seven out of the twelve Indian Health
Service (IHS) regions. These twelve IHS regions are
described in further detail on the IHS websiteTable 1 Characteristics of the programs, key informants, and











Totals 12 6(http://www.ihs.gov/images/cultureofcaring.jpg). To main-
tain program confidentiality, we identify each IHS region as
IHS Region A, B, C, etc. Twelve were outpatient programs
and six provided residential treatment. Tribes or tribal
non-profit organizations operate these programs, which
all receive additional funding from IHS. Ten programs are
located on reservations, 3 in non-reservation rural areas,
and 5 in urban areas. Participants reported that their pro-
grams had as many as 19 and as few as 3 staff and as many
as 200 and as few as 12 clients. Twenty-one individuals in
clinical administrative positions participated in key infor-
mant interviews, and 55 front-line clinicians participated in
10 focus groups (a total of 76 participants).
Ethical considerations
The Colorado Multiple Institutional Review Board reviewed
and approved all procedures, which also underwent local
review processes that always included an administrative
review and sometimes included review by a research
review committee or a formal institutional review board.
After reviewing a complete description of the study, each
participant completed written informed consent.
Data collection
The Advisory Board developed the Phase 2 Focus Group
and Key Informant Interview Guides to generate open-
ended conversations about the community the program
serves, the services provided and how they were deve-
loped, the challenges of providing these services, and
the participants' experience with selected EBTs. These
guides can be accessed on the project's web page: http://
www.ucdenver.edu/academics/colleges/PublicHealth/
research/centers/CAIANH/EBP/Pages/ProjectMeasures.
aspx. Examples of EBTs queried include 12-Step Facilita-
tion [28], Cognitive Behavioral Therapy [29], Matrix
Model [30], and Motivational Interviewing [31]. The
interview and focus group guides included open-ended
“stem” questions designed to steer the conversation
through key topics of interest to the research team and
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pressure to provide specific treatments because of
accreditation or reimbursement requirements). Key
informant interviews lasted 60 minutes and focus groups
lasted 90 minutes. Project directors had the option of
distributing interview/focus group guides prior to the
research team’s visit. The principal investigator, a psych-
iatrist who has worked with AI/AN communities for
over fifteen years, conducted all interviews, which were
recorded. Detailed notes were taken as a backup. For
their participation, programs received clinical and/or
training materials worth up to US $300.
Data analyses
All interviews were recorded and transcribed. In only
one instance was the recording quality so poor that we
relied on detailed notes for analytic purposes. After
transcription all recordings were destroyed. The authors
analyzed the transcripts using NVivo [32]. Utilizing
the principles of Grounded Theory [33], interview
transcripts were coded for key themes relevant to the
purpose of this study [34-37]. Initial codes were broken
down into smaller categories and used to inform emer-
ging hypotheses. Regular discussions among the authors
were held to achieve consensus on emerging themes and
hypotheses. Additional file 1 demonstrates how this
paper adheres to RATS qualitative research guidelines,
which are available online at http://www.biomedcentral.
com/authors/rats.Results
We identified three sets of challenges for bringing effec-
tive substance abuse treatment to AI/AN communities:
challenges associated with providing clinical support,
challenges associated with the infrastructure of the
treatment settings, and challenges associated with the
service/treatment system. These are summarized in
Table 2. Of particular importance was the way these
different sets of challenges interact synergistically with
one another, creating a highly complex context for the
delivery of these services. We first present these three
sets of challenges separately for clarity and organization
and then discuss their interrelatedness.
Challenges associated with providing clinical support
Barriers to treatment seeking and engagement:
socio-demographic
Participants cited AI/AN communities’ socioeconomic
challenges as a primary obstacle to pursuing treatment.
“There are so many survival needs that come first—
housing, a job, food,” one provider explained, adding,
“Things like outpatient treatment are probably last on
the list” (Region E, Focus Group 1). Reiterating this idea,another provider observed, “People just do not have
cars, gas, money, the ability to come here when they’re
managing tough situations at home, kids, getting here”
(Region E, Focus Group 1). As a result, providers indicated,
only a small percentage of people in need of treatment
actually receive it; and among the few who do receive it,
treatment is often undermined. Capturing clients’ predica-
ments, one provider explained, “If I don’t have a roof over
my head, then I don’t really care about finding my inner
being, you know what I mean?” (Region F, Key Informant
3). Criminal records prevent clients from receiving em-
ployment, housing, and drivers’ licenses. These housing,
transportation, and employment deficits, in turn, hinder a
solid community-level foundation for treatment and sob-
riety. “Sometimes I forget they’re [h]ere for treatment. I’m
just trying to get them a job or . . . to finish their GED . . .
because [once they] get out of treatment, if they don’t
have any of those things, they’re going to relapse most
likely” (Region C, Key Informant 5). Because relapse rates
and prevalence of misuse remain high, and substance
abuse, considered a community-wide problem, persists:
“You get one off the street and there’s two more to take
his or her place” (Region C, Key Informant 5).
Barriers to treatment engagement and process
Individual trauma histories coupled with AI/AN com-
munities’ shared history of oppression result in complex
mental health and substance abuse problems that impact
the treatment process:
“I grew up in an alcoholic home, I was raised in a
foster home, I was in a boarding school, I may have
had sexual abuse, I may have been physically abused
or emotionally abused . . . .” That’s what’s walking in
your door. It’s not simple. It’s not “I’m drinking a
six-pack a day and I really get drunk on the weekends.
Help me sober up.” [W]hat’s coming to light for our
communities is the trauma that has happened for so
many generations. . . . [S]o how do we fix that?
(Region D, Key Informant 1)
Numerous providers cited clients’ “trauma upon trauma
upon trauma” (Region B, Focus Group 1) and how these
complex trauma histories can result in a significant mis-
trust of providers as well as additional mental health
treatment needs.
Court-ordered treatment, mandated for a substantial
percentage of clients, was described by study participants
as undermining motivation, while stigma towards mental
health and substance abuse treatment further precludes
pursuing and continuing in treatment. Providers noted
the additional challenge of bringing culture into services,
due to the tremendous cultural and geographical diversity
of AI/AN communities, and the fallacy of perceiving “all
Table 2 Themes, subthemes, and examples: challenges to providing quality substance abuse treatment to
AI/AN communities
Themes Subthemes Examples
Challenges associated with providing
clinical support







Barriers to treatment engagement and process
Complex trauma histories
Diversity of patients
Integrating culture into services
Lack of motivation
Stigma of treatment
Challenges associated with the infrastructure
of treatment settings
Frontline worker challenges: fatigue and burnout
Emotional and personal investment
High caseloads
Paperwork and administrative responsibilities
Professional boundaries
Shortage of staff
Lack of program and treatment resources
Inadequate length of treatment
Lack of office supplies and space
Challenges associated with the service/
treatment system





Pressure to use Evidence-Based
Treatments (EBTs)
Excessive and unconstructive paperwork
Interference with clinical care
Not pragmatic or useful
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have 500 tribes in the United States” (Region F, Focus
Group 1). Integrating culture, critical for the many AI/AN
clients who prefer traditional rather than western ap-
proaches to treatment, is also hindered by limited cultural
resources. Providers cited few local traditional healers and
limited access to sweat lodges and powwows, most often
due to transportation and funding deficits.
Challenges associated with the infrastructure of the
treatment settings
Frontline worker challenges: fatigue and burn out
Serving clients with substantial, interrelated socioeconomic,
substance abuse, and mental health needs demands consi-
derable emotional investment from staff. As one provider
elaborated, “you have to have a certain amount of flexibility
and willingness to wade through the mud and muck of
peoples’ lives every day because these people come in
here when everything is falling apart” (Region B, Key
Informant 4). Providers explained that personal commit-
ment to clients’ treatment requires additional responsibility
to maintain professional boundaries. It can also causecaregiver fatigue, resulting in high rates of turnover. A
shortage of qualified staff, transportation barriers, and
insufficient salaries yield chronic staff openings. As a result,
“3 people have to do the work of 5” (Region C, Focus
Group 1), thereby compounding caregiver fatigue.
Overwhelming paperwork and administrative demands,
consuming up to 50% of time, further interfere with treat-
ment, leaving providers feeling like “we’re constantly
running against the clock,” “fighting to keep [our] nostrils
above the proverbial water line” (Region C, Key Informant
4). The combination of high caseloads, patients with
substantial needs, and significant administrative duties
results in staff burnout related to feelings of ineffectiveness.
Regarding her inability to meet clients’ needs, one provider
commented, “I feel the desperation of people’s voices on
the other end of the phone when they say they have to get
intro treatment now and I have to tell them three to
five months. . . . I hear their hearts drop on the floor”
(Region C, Key Informant 4). Several program directors
cited the need to provide staff with “mental health
days” to recuperate and additional praise and support
to sustain their efforts.
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Limitations in programs’ physical infrastructure and other
treatment resources add to workplace demands. Inadequate
or poorly configured physical space (office space, waiting
rooms, dining rooms, and group rooms) interferes with
client confidentiality and programming. Computers, elec-
tronics, and kitchen supplies are often lacking, and training
and treatment planning opportunities for clinical staff are
limited. Capturing a common sentiment, one program
director explained, “I’m always looking for funding. . . .
It’s a huge challenge trying to provide everything you
need….” (Region F, Key Informant 3), such as revamping
treatment curricula or integrating novel treatment ap-
proaches. Specific limitations on the length of treatment
(e.g., number of days in residential treatment, number of
sessions in outpatient treatment) interfere with meeting
clients’ significant vocational, housing, and treatment
needs. “It’s a challenge to set treatment goals and to try to
achieve them in 28 days, one provider noted, “because just
about the time you get to know them and see a little pro-
gress, they’re ready to go” (Region F, Focus Group 1).
Challenges associated with the service/treatment system
Barriers associated with providing adequate aftercare
Numerous providers cited difficulties with aftercare, spe-
cifically limited housing and treatment options. Because
housing is considered critical for sober living, inadequate
housing resources impact lengths of stay:
[Clients] know if they go back to their homeland
there’s all the drinking and drug use going on [so
they] relocate, [but] sometimes we have people
staying three weeks to a month later waiting for
housing because of the [lack of] availability and the
funding. (Region A, Focus Group 1)
Limited treatment options exacerbate transitions between
residential and intensive outpatient or community reinte-
gration, as well as between detoxification and treatment.
They also result in lengthy waitlists and unmet treatment
needs, particularly for pharmacologic treatment. “We’re
lacking beds and treatment slots,” one provider explained,
adding, “More and more people are saying ‘I need help,’
but that help isn’t there . . . because our waitlists are tre-
mendous” (Region C, Key Informant 4). Transportation
problems, including vast distances between the few
treatment facilities and clients’ limited transportation
resources, represent an additional barrier. Providers
noted that some clients travel several hours each way,
sometimes by foot or bicycle, to receive care.
Appropriateness of treatments
Funding sources frequently require using evidence-based
treatments (EBTs), but numerous programs expressedconcern about their applicability to AI/AN programs and
their lack of flexibility, considered critical for working with
AI/AN communities’ diverse needs. They also noted how
EBTs have not been studied in AI/AN communities.
“It’s all good and well to have evidence-based treatment,”
one provider explained, “but for who? Who does it work
for? . . . You’ve got to realize that it’s different in each
community” (Region G, Focus Group 1). The pressure to
use one EBT exclusively also contradicts providers’ ten-
dency to, instead, “take a little from everything—from
Matrix [an evidence-based program for substance abuse
[30]], from Red Road [an AI/AN adaptation of 12-step
treatment approaches [38,39]], from whatever you can
find” (Region D, Focus Group 1) in order to individualize
treatment. Funding requirements to use EBTs combined
with concerns about their applicability lead providers
to feel “pushed into a corner” (Region F, Focus Group
3) and additionally burdened by treatment require-
ments that do not fit clients’ needs. “It may not be
evidence-based,” one provider explained, “but what
we’re doing works. . . . I don’t know how to make it
evidence-based [but] if an expert came in who could
figure out how to do [that], that would be great” (Region
E, Key Informant 1).Excessive and unconstructive paperwork
Administrative demands from government and funding
agencies also hinder the personal connection deemed critical
for collaborating with clients and facilitating treatment:
We’re burdened with the paperwork, a treatment
plan, and everything being done in a timely manner,
especially since we’re billing the State Mental Health
Service . . . . [S]o they came and look at our files and
all of that and they want these things done so we’re
under pressure to do that. So we’re trying to balance
that out with what the person really needs and how to
connect with them. (Region F, Focus Group 2)
In addition to detracting from personalized and individu-
alized care, funding agencies’ outcome measures also fail to
portray the progress made. “What’s on paper does not show
what happens in the lobbies and hallways” (Region C, Key
Informant 4) one provider explained. Another provider
noted, “sometimes the outcomes are . . . like a baby being
born drug free . . . and that’s not something that you can
necessarily measure by a survey” (Region F, Key Informant
3). Capturing the clash between clinical responsibilities
and administrative burdens, another provider emphasized,
“You don’t provide a service just because it helps your
numbers. [You] provide a service because you have the
heart to help an individual get better” (Region C, Key
Informant 4).
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Participants’ descriptions underscored significant clinical,
program infrastructural, and service system challenges
that interfere with their efforts to provide quality individu-
alized and personalized treatment. Limited availability of
housing, employment opportunities, and transportation
(challenges associated with the service system/treatment
system) interfere with treatment and hinder the necessary
community-level foundation for sobriety, while complex
trauma histories and diverse cultural needs (challenges
associated with providing clinical support) create add-
itional demands on programs that are underfunded and
overextended. These demands also impact the work force,
which struggles with high case loads and excessive admin-
istrative responsibilities and thus lacks the time, resources,
and emotional reserve to provide quality care (challenges
associated with the infrastructure of treatment settings).
The pressure to implement EBTs and to monitor out-
comes, which creates additional demands on clinicians
and programs and which participants perceived as being
of questionable clinical significance (challenges associated
with the service/treatment system), further undermine
care, which is itself often time-limited and difficult to
access. As a result, patients are left with unmet needs,
and providers feel ineffective.
The following quotations further illustrate how clinical,
program infrastructure, and service system challenges
interact with one another:
The caseloads are too big. Everything is rush[ed]
[and] the quality is not there…. And yet, [funding
and regulatory agencies] expect that [providers]
know the evidence-based practices, they facilitate
and administrate them, and that they do the quality
one-on-one care, and the case management and the
referral on top of regular case staffings, discharge
summaries, phone calls to the community, and
helping people pick up the pieces of their lives.
[Providers] can’t do that with 25 people. . . . [Agencies]
need to let us slow down and do more quality work
with people’s lives…. I think that’s why we have the
recidivism that we do. We’re not . . . giving [clients]
what they need because our case managers are
overworked. . . . Our people are traumatized, . . .
hugely traumatized. . . . What they need is a lot of
TLC coming in. (Region C, Key Informant 5).
This quotation illustrates how high caseloads and
excessive clinical responsibilities (challenges associated
with the infrastructure of treatment settings) combined
with the pressure to use EBTs (challenges associated
with the service/treatment system) undermine the
provision of quality substance abuse treatment critical
for patients with complex trauma histories and highrecidivism rates (challenges associated with providing
clinical support).
[M]ost of our clients have [substance-abused related]
felonies [and they] can’t . . . qualify for public
housing. [Clients] get clean, [try] to get [custody of]
their kids [and try] to work full time, but there is not
suitable housing for them that they can afford. . . . [A]
lot of their family members or past friends may have
been users [and that’s] counterproductive for them to
go and live with a past user. . . . [B]ut they still have
to have a roof over their head. . . . [It] can be real
frustrating, very frustrating. And it’s frustrating on our
part too because we’re looked at as “well, we’re
coming to you for help,” but the resources just aren’t
there. . . . [W]e don’t have a resource to help with
that. (IHS Region F, Key Informant 3)
As illustrated in this quotation, the absence of housing
resources (challenges associated with the service/treatment
system) prevents clients with complex socioeconomic chal-
lenges from leaving communities with endemic substance
abuse problems (challenges associated with providing
clinical support), consequently thwarting their attempts at
sobriety. As a result, providers are left feeling frustrated
and ineffective (challenges associated with the infra-
structure of treatment settings), while clients' considerable
needs remain unaddressed.
Discussion
Our most striking finding is the powerful, synergistic
interactions between clinical, infrastructural, and service
system challenges, which create a highly complex context
for the provision of quality substance abuse treatment.
These challenges’ interrelated nature underscores the need
for integrated, comprehensive, and longer-term treatment
that address the chronic, relapsing nature of substance
use disorders and their complex medical, psychiatric,
and social comorbidities [11,40,41]. For example, inte-
grated care models can combine medical, psychiatric,
and substance abuse treatment to enhance coordination
of care [42], while telepsychiatry can provide culturally
appropriate services that traverse transportation and
other socioeconomic barriers [43-45]. Community outreach
and engagement efforts can help minority communities
overcome stigma and mistrust and develop effective,
culturally relevant treatment interventions [46,47].
Clinical factors related to cultural differences and trauma
histories [48,49]; socioeconomic factors, such as transporta-
tion and housing [50-52]; and policy measures [7] have
been identified individually as important barriers to care in
diverse settings. However, our findings suggest that these
challenges are best understood when we are mindful of
their interrelatedness with one another. This approach may
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underserved communities disproportionately afflicted by
substance abuse, where economic, social, and racial realities
underlie disparities in care [53,54].
Several of the challenges we identified have been iden-
tified by others as ones that are likely unique to AI/AN
communities. These include the tremendous need for
substance abuse services, mistrust of providers and stigma
towards substance abuse treatment, limited funding and
other resources, and questions regarding the applicability
of evidence-based practices [15,20-23]. We believe several
other challenges not previously noted–complex trauma
histories, AI/AN communities’ diversity, integrating cul-
ture into treatment, and the pressure to use EBTs
(appropriateness of treatments)–may also be unique to
providing substance abuse treatment to AI/AN com-
munities. However, the majority of the challenges
identified likely apply to the general substance abuse
patient population in the United States. Such challenges
that have been previously cited include clients’ extensive
socioeconomic needs [10-12] and treatment programs’
insufficient (qualified) staff and inadequate resources
[2-4]. Service/treatment systems’ limited aftercare options,
inadequate services to address medical and psychiatric
comorbidities [2,13], overwhelming paperwork demands,
[6] and poor integration between all phases of care from
detoxification to community reintegration have also been
noted. Because we did not include programs serving
non-AI/AN communities in this sample, this partitioning
of factors into general and AI/AN-specific categories is
largely dependent upon the admittedly limited literature
in this area, and some of the factors that we identify as
AI/AN-specific may in fact apply to substance abuse
services for other populations, particularly those focused
on serving other indigenous communities.
Additional study limitations that should be noted
include our focus on programs providing innovative
services, which may limit the applicability of these
findings to programs that do not meet this criterion.
Quantitative data from Phase 3 of this project will be
better able to describe the full scope of these issues,
though without the specific examples and detailed con-
texts provided by the qualitative analyses presented here.
In addition, we did not interview clients or community
members, who would add an important perspective on
substance abuse treatment services. This was consistent
with this project’s primary goal of describing the use of
evidence-based treatments in these programs, however
the inclusion of such interviews should be seriously
considered in future research.
Conclusions
This first multisite study of substance abuse treatment
programs serving AI/AN communities provides importantinsights into the considerable challenges these programs
face in providing quality care. Challenges associated with
providing clinical support, those associated with the
infrastructure of treatment settings, and those associated
with the service/treatment system interact to form a
highly complex set of conditions for the delivery of
these services. Our findings suggest that substance abuse
treatment services for AI/AN communities require more
integrated, individualized, comprehensive, and longer-term
approaches to care. Our framework for conceptualizing
these challenges may be useful for exploring these issues
in other diverse substance abuse treatment settings,
enabling clinicians, treatment programs, and policymakers
to better assure the provision of the highest quality
substance abuse treatment services.
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